Catalog IDs: OP-101-1003, OP-101-1004
TruSight Tumor 170 is designed to cover 170 genes associated with common solid tumors, is an enrichment-based targeted panel that simultaneously analyzes DNA and RNA, covering a wide range of genes and variant types.
The optimal range for DNA is from 40 ng to 120 ng total or 3.3 ng/µl to 10 ng/µl. The optimal range for RNA is from 40 ng to 85 ng total or 4.7 ng/µl to 10 ng/µl. Use a fluorometric-based method to quantify input.